Malhotra, Amit KumarBansal, ArikaMridha, Asit RKhaitan, Binod KVerma, Kaushal K2009-05-282009-05-282006-09-20Malhotra AK, Bansal A, Mridha AR, Khaitan BK, Verma KK. Superficial basal cell carcinoma on face treated with 5% imiquimod cream. Indian Journal of Dermatology, Venereology and Leprology. 2006 Sep-Oct; 72(5): 373-5http://imsear.searo.who.int/handle/123456789/52622Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.engAgedAminoquinolines --administration & dosageCarcinoma, Basal Cell --diagnosisFace --pathologyHumansMaleOintmentsSkin Neoplasms --diagnosisCase Reports